Replies to post #4388 on Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

What do you think about the interim data to date in the 202 PEG in light of the stroma issue?
BTW, thanks for the article. It's important to consider all angles in order
to avoid the risk of "confirmation bias".
Good luck!
-Fritz